Telemetry Investments’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,000
| Closed | -$47K | – | 203 |
|
|
2022
Q1 | $47K | Buy |
6,000
+1,657
| +38% | +$18.2K | 0.07% | 121 |
|
|
2021
Q4 | $71K | Sell |
4,343
-657
| -13% | -$13.9K | 0.09% | 143 |
|
|
2021
Q3 | $126K | Sell |
5,000
-286
| -5% | -$7.42K | 0.17% | 113 |
|
|
2021
Q2 | $176K | Buy |
5,286
+672
| +15% | +$21.7K | 0.24% | 100 |
|
|
2021
Q1 | $200K | Sell |
4,614
-10,436
| -69% | -$437K | 0.23% | 117 |
|
|
2020
Q4 | $278K | Buy |
15,050
+8,198
| +120% | +$160K | 0.47% | 68 |
|
|
2020
Q3 | $389K | Buy |
6,852
+4,881
| +248% | +$227K | 0.85% | 47 |
|
|
2020
Q2 | $59K | Sell |
1,971
-72,537
| -97% | -$2.05M | 0.16% | 62 |
|
|
2020
Q1 | $1.47M | Buy |
74,508
+49,894
| +203% | +$1.67M | 5.12% | 3 |
|
|
2019
Q4 | $1.31M | Buy |
24,614
+3,861
| +19% | +$238K | 4.36% | 7 |
|
|
2019
Q3 | $1.13M | Buy |
20,753
+2,638
| +15% | +$237K | 3.27% | 9 |
|
|
2019
Q2 | $2.07M | Buy |
18,115
+11,177
| +161% | +$1.32M | 1.6% | 14 |
|
|
2019
Q1 | $1.16M | Buy |
6,938
+680
| +11% | +$83.3K | 0.59% | 28 |
|
|
2018
Q4 | $464K | Buy |
6,258
+1,716
| +38% | +$217K | 0.3% | 79 |
|
|
2018
Q3 | $650K | Sell |
4,542
-2,099
| -32% | -$307K | 0.29% | 56 |
|
|
2018
Q2 | $948K | Buy |
6,641
+2,690
| +68% | +$405K | 0.36% | 41 |
|
|
2018
Q1 | $697K | Buy |
+3,951
| New | +$1.32M | 0.26% | 65 |
|
Other funds holding ZSAN
Telemetry Investments's ZSAN Position: Q2 2022 in Review
Telemetry Investments sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 6,000 shares — an estimated $47K sold.
Telemetry Investments first reported a position in ZSAN in Q1 2018 and held it in 17 quarters. The position peaked at $2.07M in Q2 2019. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.
- Telemetry Investments reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
- Telemetry Investments sold 6,000 Zosano Pharma Corporation shares in Q2 2022, an estimated $47K.
- Telemetry Investments first reported a position in Zosano Pharma Corporation in Q1 2018 and held it in 17 quarters.
- Telemetry Investments's Zosano Pharma Corporation position peaked at $2.07M in Q2 2019.
- 3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.
Based on Telemetry Investments's 13F filing for Q2 2022, filed 15 Aug 2022.